Form 4 for CNMD CONMED Corp
Accepted 2024-11-08 00:00:00 ET · period of report 2024-11-07 · accession 0001127602-24-026855 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-08 | 2024-11-07 | CNMD | Hartman Curt R | Pres, CEO, Dir | M - OptEx | $51.30 | +30.0K | 34.3K | +698% | +$1.54M |
| D | 2024-11-08 | 2024-11-07 | CNMD | Hartman Curt R | Pres, CEO, Dir | F - Tax | $74.76 | -24.3K | 9,996 | -71% | -$1.82M |
| D | 2024-11-08 | 2024-11-07 | CNMD | Hartman Curt R | Pres, CEO, Dir | M - OptEx | $0.00 | -30.0K | 118.3K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-07 | M | A | 30,000 | $51.30 | 34,299 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-07 | F | D | 24,303 | $74.76 | 9,996 | D | — | — | |
| 3 | Derivative | SARs (Stock Appreciation Rights) | 2024-11-07 | M | D | 30,000 | $0.00 | 118,300 | D | $51.30 · — to 2025-02-27 | 30,000 Common Stock | (F1) The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts (20%) over a five year period. |